Pasithea Therapeutics (KTTA) Income Statement (2020 - 2026)
Income Statement report data from Sep 30, 2020 to Mar 31, 2026 for Pasithea Therapeutics (KTTA).
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Reported currency: USD
| Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Sep 30, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue and COGS | ||||||||||||||||||||||
Total Revenue | - | - | - | - | - | - | - | - | - | -180.00K | 180K | - | - | 240K (+9.09%) | 220K (+2100.00%) | 10K (0.00%) | 10K (-50.00%) | 20K | - | - | - | - |
Gross Profit | - | - | - | - | - | - | - | - | - | - | - | - | - | -130.00K | 130K | - | - | - | - | - | - | - |
Operating Expenses | ||||||||||||||||||||||
Research And Development | 2.94M (+7.30%) | 2.74M (+101.47%) | 1.36M (-36.74%) | 2.15M (+24.28%) | 1.73M (+14.57%) | 1.51M (-4.43%) | 1.58M (-33.05%) | 2.36M (+34.86%) | 1.75M (-47.76%) | 3.35M (+106.79%) | 1.62M (-20.20%) | 2.03M (+84.55%) | 1.10M (-20.86%) | 1.39M (+8.59%) | 1.28M | - | - | - | - | - | - | - |
Selling General And Administrative | 1.93M (-74.30%) | 7.51M (+329.14%) | 1.75M (+5.42%) | 1.66M (-14.87%) | 1.95M (+11.43%) | 1.75M (+23.24%) | 1.42M (-10.69%) | 1.59M (-30.57%) | 2.29M (+27.22%) | 1.80M (-16.67%) | 2.16M (+20.00%) | 1.80M (-15.09%) | 2.12M (-20.30%) | 2.66M (+3.10%) | 2.58M (-1.15%) | 2.61M (+25.48%) | 2.08M (+6.67%) | 1.95M (+53.54%) | 1.27M (+73.97%) | 730K (+32.73%) | 550K (+5400.00%) | 10K |
Operating Expenses | 4.88M (-52.44%) | 10M (+229.90%) | 3.11M (-18.37%) | 3.81M (+3.53%) | 3.68M (+12.88%) | 3.26M (+8.67%) | 3.00M (-24.05%) | 3.95M (-2.23%) | 4.04M (-21.55%) | 5.15M (+35.88%) | 3.79M (-1.04%) | 3.83M (+19.31%) | 3.21M | -7.85M | 3.86M (+47.89%) | 2.61M (+25.48%) | 2.08M (+6.67%) | 1.95M (+53.54%) | 1.27M (+73.97%) | 730K (+32.73%) | 550K (+5400.00%) | 10K |
Depreciation And Amortization | - | - | 20K | - | - | - | 10K (0.00%) | 10K | - | 10K | - | - | - | - | - | - | 10K | - | - | - | - | - |
Operating Income | ||||||||||||||||||||||
Operating Income | -4.88M (-52.44%) | -10.26M (+229.90%) | -3.11M (-18.37%) | -3.81M (+3.53%) | -3.68M (+12.88%) | -3.26M (+8.67%) | -3.00M (-24.05%) | -3.95M (-2.23%) | -4.04M (-21.55%) | -5.15M (+35.88%) | -3.79M (-1.04%) | -3.83M (+19.31%) | -3.21M (-20.54%) | -4.04M (+4.66%) | -3.86M (+47.89%) | -2.61M (+25.48%) | -2.08M (+6.12%) | -1.96M (+54.33%) | -1.27M (+73.97%) | -730.00K (+32.73%) | -550.00K (+5400.00%) | -10.00K |
Ebit | -4.88M (-52.44%) | -10.26M (+229.90%) | -3.11M (-18.37%) | -3.81M (+3.53%) | -3.68M (+12.88%) | -3.26M (+8.67%) | -3.00M (-24.05%) | -3.95M (-2.23%) | -4.04M (-21.55%) | -5.15M (+35.88%) | -3.79M (-1.04%) | -3.83M (+19.31%) | -3.21M (-20.54%) | -4.04M (+4.66%) | -3.86M (+47.89%) | -2.61M (+25.48%) | -2.08M (+6.12%) | -1.96M (+54.33%) | -1.27M (+73.97%) | -730.00K (+32.73%) | -550.00K (+5400.00%) | -10.00K |
EBITDA | -2.87M (-72.03%) | -10.26M (+232.04%) | -3.09M (-18.90%) | -3.81M (+3.53%) | -3.68M (+12.88%) | -3.26M (+8.67%) | -3.00M (-23.86%) | -3.94M (-2.48%) | -4.04M (-23.19%) | -5.26M (+45.71%) | -3.61M (-6.96%) | -3.88M (+20.87%) | -3.21M (-1.83%) | -3.27M (-28.76%) | -4.59M (+72.56%) | -2.66M (+28.50%) | -2.07M (+21.76%) | -1.70M (+11.11%) | -1.53M (+109.59%) | -730.00K (+32.73%) | -550.00K (+5400.00%) | -10.00K |
Other Income / Expenses | ||||||||||||||||||||||
Interest Expense | - | - | - | - | - | - | - | - | - | 110K | - | -120.00K | 10K | - | - | - | - | - | - | - | - | - |
Net Interest Income | - | - | - | - | - | - | - | - | - | -110.00K | - | 120K | -10.00K | - | - | - | - | - | - | - | - | - |
Other Non Operating Income | 2.01M (+20000.00%) | 10K (0.00%) | 10K (0.00%) | 10K (0.00%) | 10K (-97.14%) | 350K | - | 110K (-26.67%) | 150K (-68.09%) | 470K (+161.11%) | 180K (+50.00%) | 120K | -10.00K | 860K | -340.00K | 420K (-49.40%) | 830K (-64.38%) | 2.33M | -250.00K | - | - | - |
Net Income | ||||||||||||||||||||||
Income Before Tax | -2.87M (-71.61%) | -10.11M (+232.57%) | -3.04M (-18.28%) | -3.72M (+4.49%) | -3.56M (+11.95%) | -3.18M (+6.00%) | -3.00M (-22.48%) | -3.87M (+0.26%) | -3.86M (-23.26%) | -5.03M (+39.34%) | -3.61M (+0.28%) | -3.60M (+10.09%) | -3.27M (-19.26%) | -4.05M (-3.34%) | -4.19M (+91.32%) | -2.19M (+69.77%) | -1.29M | 630K | -1.53M (+109.59%) | -730.00K (+32.73%) | -550.00K (+5400.00%) | -10.00K |
Net Income From Continuing Operations | -2.87M (-71.61%) | -10.11M (+232.57%) | -3.04M (-18.28%) | -3.72M (+4.49%) | -3.56M (+11.95%) | -3.18M (+6.00%) | -3.00M (-22.48%) | -3.87M (+0.26%) | -3.86M (-23.56%) | -5.05M (+39.89%) | -3.61M (-3.99%) | -3.76M (+6.21%) | -3.54M (-30.86%) | -5.12M (+11.55%) | -4.59M (+72.56%) | -2.66M (+69.43%) | -1.57M | 630K | -1.53M (+109.59%) | -730.00K (+32.73%) | -550.00K (+5400.00%) | -10.00K |
Net Income | -2.87M (-71.61%) | -10.11M (+232.57%) | -3.04M (-18.28%) | -3.72M (+4.49%) | -3.56M (+11.95%) | -3.18M (+6.00%) | -3.00M (-22.48%) | -3.87M (+0.26%) | -3.86M (-23.56%) | -5.05M (+39.89%) | -3.61M (-3.99%) | -3.76M (+6.21%) | -3.54M (-30.86%) | -5.12M (+11.55%) | -4.59M (+72.56%) | -2.66M (+69.43%) | -1.57M | 630K | -1.53M (+109.59%) | -730.00K (+32.73%) | -550.00K (+5400.00%) | -10.00K |
Comprehensive Income Net Of Tax | -2.84M (-86.09%) | -20.41M (+575.83%) | -3.02M (-18.60%) | -3.71M (+4.21%) | -3.56M (-74.41%) | -13.91M (+359.08%) | -3.03M (-21.71%) | -3.87M (+0.26%) | -3.86M (-75.83%) | -15.97M (+341.16%) | -3.62M (-3.72%) | -3.76M (+6.21%) | -3.54M (-74.59%) | -13.93M (+198.29%) | -4.67M (+72.32%) | -2.71M (-13.97%) | -3.15M (+44.50%) | -2.18M (+42.48%) | -1.53M (+109.59%) | -730.00K (+32.73%) | -550.00K (+5400.00%) | -10.00K |